Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：4

作者：

Rodriguez, Cesar A. ^{[1
]}

Martin, Teresa ^{[1
]}

Lozano, Rebeca ^{[1
]}

Gomez, Amalia ^{[1
]}

Cruz, Juan J. ^{[1
]}

机构：

[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain

来源：

BREAST JOURNAL | 2017年 / 23卷 / 06期

关键词：

bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;

D O I：

10.1111/tbj.12913

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.

引用

页码：745 / 746

页数：2

共 50 条

[31] Association paclitaxel-bevacizumab as treatment for metastatic breast cancer [J].

Pioud, Virginie ;

Chemelle, Mathilde ;

Mantelin, Myriam ;

Duban, Martine .

PHARMACY WORLD & SCIENCE, 2009, 31 (02) :276-276

[32] Bevacizumab in the treatment of metastatic breast cancer: three case reports [J].

Ferreira, Ana ;

Vieira, Claudia ;

Rodrigues, Ana ;

Pereira, Deolinda ;

Rodrigues, Helena ;

Davila, Cristina ;

Bento, Sandra .

CURRENT OPINION IN ONCOLOGY, 2011, 23 :S11-S19

[33] Successful treatment of quadriparesis from radiation myelopathy with bevacizumab in a patient with metastatic breast cancer [J].

Shah, Nirja ;

Ranjan, Surabhi .

BMJ CASE REPORTS, 2022, 15 (02)

[34] Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer [J].

Fang, Kunpeng ;

Wang, Jie ;

Yuan, Jianyong ;

Sui, Chengjun ;

Zhi, Jiajun ;

Xia, Yong ;

Sun, Minmin .

CANCER REPORTS, 2024, 7 (02)

[35] Perforation of the Nasal Septum in a Colorectal Cancer Patient Treated With Aflibercept: A Case Report [J].

Fuentes, Javier David Benitez ;

Lorenzo, Alfonso Lopez de Sa ;

Elias, Alberto Elpidio Calvo ;

Rojas, Carmen Toledano ;

Ortega, Monica Granja .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)

[36] Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: A case report and review of the literature [J].

Fujii Y. ;

Hirahara N. ;

Kaji S. ;

Taniura T. ;

Hyakudomi R. ;

Yamamoto T. ;

Tajima Y. .

Journal of Medical Case Reports, 12 (1)

[37] Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy [J].

Perroud, Herman A. ;

Alasino, Carlos M. ;

Rico, Maria J. ;

Queralt, Francisco ;

Pezzotto, Stella M. ;

Rozados, Viviana R. ;

Scharovsky, O. Graciela .

FUTURE ONCOLOGY, 2016, 12 (10) :1233-1242

[38] Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis [J].

Cai, Jun ;

Ma, Hong ;

Huang, Fang ;

Zhu, Dichao ;

Bi, Jianping ;

Ke, Yang ;

Zhang, Tao .

WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11

[39] Dramatic Improvement of Pulmonary Tumor Thrombotic Microangiopathy in a Breast Cancer Patient Treated With Bevacizumab [J].

Kimura, Aki ;

Yamada, Akimitsu ;

Oshi, Masanori ;

Nakayama, Mina ;

Komura, Naohiro ;

Sugano, Teruyasu ;

Yamamoto, Shinya ;

Narui, Kazutaka ;

Endo, Itaru .

WORLD JOURNAL OF ONCOLOGY, 2023, 14 (06) :575-579

[40] Brain Necrosis in Patients With Metastatic Lung and Breast Cancer Successfully Treated With Bevacizumab [J].

Raez, L. ;

Botero, A. ;

Khan, A. ;

Izquierdo, P. ;

Castellon, I. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S241-S241

← 1 2 3 4 5 →